# WEAKNESS CLOSING RESULTS FOR CHATGPT

## 1. Audit verdict
- Verdict: READY
- Critical issues: 0
- High issues: 1 (`validation_all` files include diagnostic test columns; not used for selection)
- Ready for conclusion: YES
- Test leakage: NO
- Metric consistency: PASS
- Manual-review consistency: PASS

## 2. V2 baseline
| Dataset | Policy | Precision | Recall | Specificity | FP | FN | Cost | MR Rate |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| taiwan | V2 CatBoost manual-review | 0.529 | 0.575 | 0.854 | 680 | 564 | 2705.500 | 0.295 |
| heloc | V2 Scorecard manual-review | 0.683 | 0.846 | 0.574 | 403 | 158 | 764.500 | 0.270 |

## 3. Manual-review metric repair
- Final Attempt repaired? YES, repaired into explicit 3x2 manual-review bucket tables.
- Critical failures remaining? NO for repaired 3x2 identities.
- Can Final Attempt be final? NO. It remains appendix/robustness only unless a future full audit promotes it.
- Use as appendix? YES.

## 4. Taiwan recall improvement
| Candidate | Recall | Precision | Specificity | FP | FN | Cost | MR Rate | Delta vs V2 | Comment |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| taiwan_recall_cand_003289 | 0.633 | 0.463 | 0.791 | 976 | 487 | 1993.200 | 0.295 | recall +0.058, FP +296, FN -77 | V3 audit candidate; recall improves but precision/specificity drop. |
| taiwan_recall_cand_003394 | 0.622 | 0.478 | 0.807 | 901 | 502 | 2034.300 | 0.289 | recall +0.047, FP +221, FN -62 | V3 audit candidate; recall improves but precision/specificity drop. |
| taiwan_recall_cand_003399 | 0.619 | 0.480 | 0.809 | 891 | 505 | 2025.600 | 0.291 | recall +0.044, FP +211, FN -59 | V3 audit candidate; recall improves but precision/specificity drop. |

## 5. Capacity-aware review
| Dataset | Model | Capacity | Capture Rate | Precision@K | Lift@K | Low-risk Default Rate | Comment |
| --- | --- | --- | --- | --- | --- | --- | --- |
| taiwan | SCRE-Optimized probability ranking | 0.200 | 0.529 | 0.585 | 2.645 | 0.130 | Capacity/review-prioritization evidence, not final automatic decision. |
| taiwan | SCRE-Pareto probability ranking | 0.200 | 0.526 | 0.582 | 2.630 | 0.131 | Capacity/review-prioritization evidence, not final automatic decision. |
| taiwan | Best EBM/monotonic model: Monotonic LightGBM | 0.200 | 0.520 | 0.575 | 2.600 | 0.133 | Capacity/review-prioritization evidence, not final automatic decision. |
| heloc | SCRE-Optimized probability ranking | 0.200 | 0.340 | 0.884 | 1.698 | 0.429 | Capacity/review-prioritization evidence, not final automatic decision. |
| heloc | Best EBM/monotonic model: EBM | 0.200 | 0.338 | 0.878 | 1.689 | 0.431 | Capacity/review-prioritization evidence, not final automatic decision. |
| heloc | SCRE-Pareto probability ranking | 0.200 | 0.334 | 0.868 | 1.669 | 0.433 | Capacity/review-prioritization evidence, not final automatic decision. |

## 6. HELOC specificity improvement
| Candidate | Specificity | Recall | Precision | FP | FN | Cost | MR Rate | Delta vs V2 | Comment |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| heloc_spec_cand_000065 | 0.676 | 0.782 | 0.724 | 307 | 224 | 1427.000 | 0.000 | specificity +0.101, FP -96, cost +662.5 | Specificity improves; cost increases; appendix/V3 candidate. |
| heloc_spec_cand_040371 | 0.631 | 0.811 | 0.705 | 349 | 194 | 1319.000 | 0.000 | specificity +0.057, FP -54, cost +554.5 | Specificity improves; cost increases; appendix/V3 candidate. |
| heloc_spec_cand_040365 | 0.621 | 0.815 | 0.700 | 359 | 190 | 1309.000 | 0.000 | specificity +0.046, FP -44, cost +544.5 | Specificity improves; cost increases; appendix/V3 candidate. |

## 7. Cost sensitivity and decision curve
| Dataset | Best Stable System | Cost Robust? | Useful Threshold Range | Comment |
| --- | --- | --- | --- | --- |
| Taiwan | V2 CatBoost manual-review | YES under core FN-dominant / moderate review-cost assumptions | Decision curves: SCRE ranking useful in broad ranges; not final selector | Cost uncertainty does not replace V2; identifies V3 candidates. |
| HELOC | V2 Scorecard manual-review | YES; SCRE threshold also competitive but not final | Decision curves: SCRE/capacity ranking useful for review prioritization | V2 remains safest operational evidence. |

## 8. Instance-dependent cost
| Dataset | Did final decision change? | Best System | Comment |
| --- | --- | --- | --- |
| Taiwan | PARTIALLY / not final | Taiwan recall candidate under proxy-cost definitions | Recall candidate lowers proxy instance-dependent cost, but remains V3 audit candidate. |
| HELOC | NO | V2 Scorecard manual-review | V2 remains best under HELOC proxy-cost definitions. |

## 9. SCRE strengthening
| Dataset | SCRE Role | Capture@20 | Lift@20 | Safe Claim |
| --- | --- | --- | --- | --- |
| taiwan | Review prioritization / reliability-aware framework | 0.529 | 2.645 | SCRE supports Top-K review prioritization; not dominant classifier. |
| heloc | Review prioritization / reliability-aware framework | 0.340 | 1.698 | SCRE supports Top-K review prioritization; not dominant classifier. |

## 10. Segment-aware threshold
| Dataset | Candidate | Better than V2? | Risk | Use |
| --- | --- | --- | --- | --- |
| Taiwan | limit/utilization segment policies | NO clear replacement | Overfitting; recall not improved beyond V2 | Appendix only |
| HELOC | revolving_burden_terciles | Specificity improves, cost worsens | Not audit-ready; trade-off heavy | Appendix / V3 candidate |

## 11. Temporal robustness
- Real temporal validation possible? NO.
- Result: No verified timestamp/application-date field exists. Only pseudo/order-based and random-partition diagnostics were produced.
- Use as: LIMITATION ONLY / APPENDIX DIAGNOSTIC.

## 12. V2 vs V3 final decision
| Dataset | Final Version | Reason |
| --- | --- | --- |
| Taiwan | V2 | Only audit-ready final operational evidence; recall candidate not audit-ready. |
| HELOC | V2 | Scorecard manual-review remains safest; specificity candidates increase cost. |

## 13. What improved?
- Taiwan recall: improved in candidate policy from V2 0.575 to up to 0.633, but candidate is not final.
- Manual review workload: segment/capacity candidates can reduce workload, but trade off recall/cost.
- HELOC specificity: improved in candidate policy from V2 0.574 to 0.676, but cost rises.
- Cost robustness: V2 remains stable under core assumptions; instance-dependent proxy analysis clarifies exposure-sensitive trade-offs.
- SCRE role: stronger as review-prioritization/reliability-aware framework, not classifier.
- Audit status: final weakness-closing audit READY with 0 critical issues.

## 14. What did not improve?
- No V3 candidate became audit-ready final replacement.
- Taiwan recall gains reduce precision/specificity and increase FP.
- HELOC specificity gains increase cost and reduce recall.
- Real temporal deployment validation remains impossible due to missing timestamps.
- Real bank loss/cost data remains unavailable; only sensitivity/proxy-cost analysis is possible.
- SCRE still should not be claimed as a dominant classifier.

## 15. Final recommendation from the system
- Use V2 as final: YES.
- Use V3 as final: NO.
- Use Final Attempt as appendix: YES.
- Proceed to conclusion: YES.

## 16. Questions for ChatGPT
1. Bu sonuçlara göre V2 mi kalmalı, V3 mü?
2. Hangi zayıflıklar gerçekten kapandı?
3. Hangi sonuçlar ana rapora girmeli?
4. Hangi sonuçlar appendix olmalı?
5. Artık sonuca geçmeli miyim?

## Source audit note
The final weakness-closing audit is READY. The only high caveat is that some `validation_all` files include diagnostic test columns for all candidates. They were not used for final selection and must not be cited as selection evidence.
